Bladder Cancer,Genitourinary Cancer Gemcitabine/Cisplatin ± Berzosertib in mUC: Extended Follow-up Mar 26, 2024
Bladder Cancer,Genitourinary Cancer APL-1202 +Tislelizumab: Exceeding pCR Rate Thresholds Mar 07, 2024
Bladder Cancer,Genitourinary Cancer Neoadjuvant NIVO & Nab-ABX in MIBC: NURE-Combo Study Feb 22, 2024
